New heart drug shows promise in major trial for thick heart muscle condition
Disease control
Completed
This study tested a new medication, aficamten, in 282 adults with a heart condition that makes the heart muscle too thick and blocks blood flow. The goal was to see if the drug could improve exercise ability and quality of life compared to a placebo. Participants took the drug or…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 17, 2026 06:45 UTC